Portfolio (Quarterly)
Guide ↗
State of New Jersey Common Pension Fund D
· CIK 0001483066| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 101 | GERN | GERON CORP | Healthcare | 163,622.0 | $244K | 0.00% | NEW | — | $1.49 | -9.4% |
| 102 | URGN | UROGEN PHARMA LTD | Healthcare | 13,439.0 | $242K | 0.00% | NEW | — | $17.98 | +95.5% |
| 103 | PGEN | PRECIGEN INC | Healthcare | 60,502.0 | $234K | 0.00% | NEW | — | $3.87 | +38.5% |
| 104 | MBX | MBX BIOSCIENCES INC | Healthcare | 7,673.0 | $229K | 0.00% | NEW | — | $29.85 | +55.4% |
| 105 | ANNX | ANNEXON INC | Healthcare | 40,753.0 | $226K | 0.00% | NEW | — | $5.54 | -4.7% |
| 106 | QURE | UNIQURE NV | Healthcare | 13,685.0 | $224K | 0.00% | NEW | — | $16.35 | +199.9% |
| 107 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 49,296.0 | $222K | 0.00% | NEW | — | $4.50 | -1.1% |
| 108 | TBPH | THERAVANCE BIOPHARMA INC | Healthcare | 12,988.0 | $211K | 0.00% | NEW | — | $16.23 | +4.6% |
| 109 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 46,807.0 | $209K | 0.00% | NEW | — | $4.47 | +53.5% |
| 110 | XNCR | XENCOR INC | Healthcare | 17,084.0 | $206K | 0.00% | NEW | — | $12.06 | +16.2% |
| 111 | KURA | KURA ONCOLOGY INC | Healthcare | 25,278.0 | $206K | 0.00% | NEW | — | $8.13 | +27.7% |
| 112 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 10,864.0 | $203K | 0.00% | NEW | — | $18.64 | +13.8% |
| 113 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 38,113.0 | $202K | 0.00% | NEW | — | $5.29 | -61.1% |
| 114 | — | ATAIBECKLEY INC | — | 56,493.0 | $200K | 0.00% | NEW | — | $3.54 | — |
| 115 | ARVN | ARVINAS INC | Healthcare | 18,657.0 | $198K | 0.00% | NEW | — | $10.60 | -23.2% |
| 116 | OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | 12,901.0 | $192K | 0.00% | NEW | — | $14.91 | -29.4% |
| 117 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 14,978.0 | $190K | 0.00% | NEW | — | $12.67 | -29.7% |
| 118 | JANX | JANUX THERAPEUTICS INC | Healthcare | 13,361.0 | $186K | 0.00% | NEW | — | $13.90 | +7.3% |
| 119 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 15,997.0 | $178K | 0.00% | NEW | — | $11.11 | -2.3% |
| 120 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 10,553.0 | $174K | 0.00% | NEW | — | $16.45 | +25.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
30.9%
Financial Services
11.9%
Consumer Cyclical
10.1%
Communication Services
9.6%
Healthcare
9.5%
Industrials
9.2%
Consumer Defensive
5.0%
Real Estate
4.9%
Energy
4.2%
Utilities
2.7%